Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-01-19-Speech-3-238-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110119.20.3-238-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"The directive on the application of patients’ rights in cross-border healthcare is an extremely important document for EU citizens, and so I have followed work on the issue very attentively. I am pleased to note that the directive gives patients the right to choose the place where healthcare will be provided, thereby strengthening the common market, which is the main subject of my work in the European Parliament. This also means that it introduces adaptations which take account of citizens’ freedom to travel and work in any EU Member State. This directive, which could be called a Schengen for health, covers such issues as the mutual recognition of prescriptions, an end to discrimination against patients on the grounds of country of origin and the removal of the need for additional insurance abroad.
The issue of counterfeit drugs and medicinal products is another very important issue from the point of view of the common market. The directive stresses that they are a serious problem, particularly in the context of cross-border healthcare, and the same is true for medical tourism. The directive tackles this problem by ensuring that the costs of treatment are reimbursed to the level guaranteed in the country of origin, or, if the treatment or procedure cost less than this sum, that the actual costs incurred are reimbursed. The solutions introduced will help to improve the situation of patients in the European Union and will strengthen the common market, and so I voted in favour of adoption of the directive."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples